Healthcare Analysts, ahead of the upcoming AASLD Annual Meeting, discuss emerging treatment options for Chronic Hepatitis B (relevant companies: ABUS, HOOK, BRNS, VIR, GSK, ALGS, GILD) on an Analyst/Industry conference call to be held on October 22.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABUS:
- Arbutus Biopharma Highlights Imdusiran’s Potential in Hepatitis B
- Arbutus Biopharma announces abstracts highlighting imdusiran data
- Arbutus Biopharma CSO Michael Sofia Announces Retirement Plans
- Arbutus Biopharma to Share Insights at Viral Hepatitis Conference
- Biotech Alert: Searches spiking for these stocks today
Questions or Comments about the article? Write to editor@tipranks.com